35.71
price down icon0.42%   -0.15
after-market Dopo l'orario di chiusura: 36.23 0.52 +1.46%
loading
Precedente Chiudi:
$35.86
Aprire:
$36.14
Volume 24 ore:
17,461
Relative Volume:
0.47
Capitalizzazione di mercato:
$218.37M
Reddito:
-
Utile/perdita netta:
$-7.12M
Rapporto P/E:
-15.53
EPS:
-2.3
Flusso di cassa netto:
$-6.82M
1 W Prestazione:
+3.06%
1M Prestazione:
-10.19%
6M Prestazione:
-17.15%
1 anno Prestazione:
+1,407%
Intervallo 1D:
Value
$34.03
$36.23
Intervallo di 1 settimana:
Value
$30.51
$36.51
Portata 52W:
Value
$2.15
$54.30

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
Nome
Monopar Therapeutics Inc
Name
Telefono
(847) 388-0349
Name
Indirizzo
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
Dipendente
16
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
MNPR's Discussions on Twitter

Confronta MNPR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MNPR
Monopar Therapeutics Inc
35.71 219.29M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-07 Iniziato Cantor Fitzgerald Overweight
2025-06-23 Iniziato Chardan Capital Markets Buy
2025-03-19 Ripresa Piper Sandler Overweight
2025-01-10 Iniziato Piper Sandler Overweight
2024-10-11 Iniziato Rodman & Renshaw Buy
2021-01-28 Iniziato ROTH Capital Buy
Mostra tutto

Monopar Therapeutics Inc Borsa (MNPR) Ultime notizie

pulisher
02:47 AM

MNPR FY2025 EPS Increased by Brookline Capital Management - Defense World

02:47 AM
pulisher
12:18 PM

How to use a screener to detect Monopar Therapeutics Inc. breakoutsJuly 2025 Action & Long-Term Growth Stock Strategies - Newser

12:18 PM
pulisher
Aug 16, 2025

Using Bollinger Bands to evaluate Monopar Therapeutics Inc.2025 Trading Recap & AI Enhanced Trading Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Chart based exit strategy for Monopar Therapeutics Inc.Portfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can swing trading help recover from Monopar Therapeutics Inc. lossesMarket Rally & AI Enhanced Execution Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Volume Confirm Reversal in Monopar Therapeutics Inc.Quarterly Growth Report & Real-Time Chart Breakout Alerts - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

Traders Consider Averaging Down in Monopar Therapeutics Inc.July 2025 Short Interest & Verified Chart Pattern Signals - metal.it

Aug 16, 2025
pulisher
Aug 16, 2025

Monopar Therapeutics Inc. stock trend forecastPortfolio Performance Report & AI Forecasted Entry/Exit Points - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is it too late to sell Monopar Therapeutics Inc.July 2025 PostEarnings & Community Verified Trade Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Monopar Therapeutics Inc. stock reversal real or fakeBond Market & Stepwise Entry/Exit Trade Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Does Monopar Therapeutics Inc. fit your quant trading model2025 Winners & Losers & Fast Entry High Yield Tips - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Published on: 2025-08-15 22:52:10 - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Applying Elliott Wave Theory to Monopar Therapeutics Inc.July 2025 Fed Impact & Advanced Technical Signal Analysis - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

How to escape a deep drawdown in Monopar Therapeutics Inc.Day Trade & Capital Efficiency Focused Strategies - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

What the charts say about Monopar Therapeutics Inc. todayJuly 2025 Weekly Recap & Capital Efficiency Focused Strategies - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Will Monopar Therapeutics Inc. price bounce be sustainableJuly 2025 Highlights & Verified Entry Point Signals - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

How to monitor Monopar Therapeutics Inc. with trend dashboards2025 Winners & Losers & Technical Pattern Based Buy Signals - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Does Monopar Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Final Week & Technical Pattern Recognition Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Monopar Therapeutics (NASDAQ:MNPR) Earns “Buy” Rating from Chardan Capital - Defense World

Aug 15, 2025
pulisher
Aug 15, 2025

Is Monopar Therapeutics Inc. stock showing strong momentum2025 Investor Takeaways & Real-Time Buy Zone Alerts - thegnnews.com

Aug 15, 2025
pulisher
Aug 14, 2025

Monopar Therapeutics Inc. Attempts Reversal From Key Support2025 Sector Review & Free High Return Stock Watch Alerts - thegnnews.com

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Monopar Therapeutics Inc. stock price move sharply2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Combining price and volume data for Monopar Therapeutics Inc.2025 Sector Review & Growth Oriented Trade Recommendations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

When is the best time to buy Monopar Therapeutics Inc. stockM&A Rumor & Daily Stock Trend Reports - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Monopar Therapeutics Inc. stock volume spike explained2025 Geopolitical Influence & Weekly Breakout Watchlists - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will Monopar Therapeutics Inc. outperform the market2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Monopar Therapeutics Reports Increased R&D Expenses - TipRanks

Aug 13, 2025
pulisher
Aug 12, 2025

Monopar Therapeutics Inc. Breaks Losing Streak — Is the Trend ReversingTop Gaining Picks With Entry Signals Identified - 선데이타임즈

Aug 12, 2025
pulisher
Aug 12, 2025

Monopar Therapeutics Inc. Reports Q2 2025 Financial Results and Progress on ALXN1840 and MNPR-101 Clinical Trials - Quiver Quantitative

Aug 12, 2025
pulisher
Aug 12, 2025

Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments - The Manila Times

Aug 12, 2025
pulisher
Aug 12, 2025

Monopar Therapeutics SEC 10-Q Report - TradingView

Aug 12, 2025
pulisher
Aug 12, 2025

Monopar Q2 Earnings: $53.3M Cash Position Funds Wilson Disease Drug NDA | MNPR Stock News - Stock Titan

Aug 12, 2025
pulisher
Aug 12, 2025

Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Aug 12, 2025
pulisher
Aug 11, 2025

Will Monopar Therapeutics Inc. stock go up soonAI Pattern Recognition and Trade Prediction - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Monopar Therapeutics Inc. stock trendline breakdownRisk Managed Watchlist with Breakout Picks - Newser

Aug 11, 2025
pulisher
Aug 09, 2025

How Monopar Therapeutics Inc. stock performs during market volatilityStock Price Prediction Using AI Tools - Newser

Aug 09, 2025

Monopar Therapeutics Inc Azioni (MNPR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Capitalizzazione:     |  Volume (24 ore):